111 related articles for article (PubMed ID: 10559598)
41. A case of paraneoplastic pemphigus with antidesmoglein 1 antibodies as determined by immunoblotting.
Martel P; Gilbert D; Labeille B; Kanitakis J; Joly P
Br J Dermatol; 2000 Apr; 142(4):812-3. PubMed ID: 10792239
[No Abstract] [Full Text] [Related]
42. Detailed profiling of anti-desmoglein autoantibodies identifies anti-Dsg1 reactivity as a key driver of disease activity and clinical expression in pemphigus vulgaris.
Naseer SY; Seiffert-Sinha K; Sinha AA
Autoimmunity; 2015 Jun; 48(4):231-41. PubMed ID: 25384535
[TBL] [Abstract][Full Text] [Related]
43. Sensitivity of indirect immunofluorescence and ELISA in detecting intercellular antibodies in endemic pemphigus foliaceus (Fogo Selvagem).
Cunha PR; Bystryn JC; Medeiros EP; de Oliveira JR
Int J Dermatol; 2006 Aug; 45(8):914-8. PubMed ID: 16911373
[TBL] [Abstract][Full Text] [Related]
44. Unusual pemphigus phenotype in the presence of a Dsg1 and Dsg3 autoantibody profile.
Müller E; Kernland K; Caldelari R; Wyder M; Balmer V; Hunziker T
J Invest Dermatol; 2002 Mar; 118(3):551-5. PubMed ID: 11874500
[No Abstract] [Full Text] [Related]
45. Anagen hair loss, anti-desmoglein 1, and pemphigus disease area index: a significant relationship?
Fard GD; Khosravi H; Ghayoumi A; Balighi K; Ghandi N; Teimourpour A; Daneshpazhooh M
J Dtsch Dermatol Ges; 2017 Sep; 15(9):946-948. PubMed ID: 28872241
[No Abstract] [Full Text] [Related]
46. [Case no. 3. Bullous dermatosis].
Battistella M
Ann Pathol; 2013 Jun; 33(3):187-92. PubMed ID: 23790659
[No Abstract] [Full Text] [Related]
47. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
48. Pemphigus foliaceus with prominent neutrophilic pustules.
Matsuo K; Komai A; Ishii K; Futei Y; Amagai M; Deguchi H; Danno K; Hashimoto T
Br J Dermatol; 2001 Jul; 145(1):132-6. PubMed ID: 11453922
[TBL] [Abstract][Full Text] [Related]
49. Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production.
Nishifuji K; Amagai M; Kuwana M; Iwasaki T; Nishikawa T
J Invest Dermatol; 2000 Jan; 114(1):88-94. PubMed ID: 10620121
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris.
Sharma VK; Prasad HR; Khandpur S; Kumar A
Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783
[TBL] [Abstract][Full Text] [Related]
51. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
[TBL] [Abstract][Full Text] [Related]
52. Who will develop pemphigus foliaceus?
Tzu J; Romagosa Y; Kirsner RS
J Invest Dermatol; 2009 Jan; 129(1):6. PubMed ID: 19078981
[No Abstract] [Full Text] [Related]
53. Anti-skin specific autoantibodies detected by a new immunofluorescence multiplex biochip method in patients with autoimmune bullous diseases.
Tampoia M; Zucano A; Villalta D; Antico A; Bizzaro N
Dermatology; 2012; 225(1):37-44. PubMed ID: 22907099
[TBL] [Abstract][Full Text] [Related]
54. Exacerbation of pemphigus foliaceus after tetanus vaccination accompanied by synthesis of auto-antibodies against paraneoplastic pemphigus antigens.
Korang K; Ghohestani R; Krieg T; Uitto J; Hunzelmann N
Acta Derm Venereol; 2002; 82(6):482-3. PubMed ID: 12575868
[No Abstract] [Full Text] [Related]
55. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
Atzori L; Deidda S; Aste N
G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
[TBL] [Abstract][Full Text] [Related]
56. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic features of pemphigus vulgaris in patients with bullous pemphigoid. Molecular analysis of autoantibody profile.
Sami N; Bhol KC; Beutner EH; Plunkett RW; Leiferman KM; Ahmed AR
Dermatology; 2002; 204(2):108-17. PubMed ID: 11937735
[TBL] [Abstract][Full Text] [Related]
58. Pemphigus vulgaris associated with systemic lupus erythematosus.
Kuchabal DS; Kuchabal SD; Pandit AM; Nashi HK
Int J Dermatol; 1998 Aug; 37(8):636-8. PubMed ID: 9732020
[No Abstract] [Full Text] [Related]
59. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
60. The value of desmoglein 1 and 3 antibody ELISA testing in patients with pemphigus.
Zone JJ
Arch Dermatol; 2009 May; 145(5):585-7. PubMed ID: 19451505
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
